Rawat, Manoj, Natasha , Manners, Vishnu, Priya , Abhishesh Kumar , Mehata and Madaswamy S, Muthu (2022) Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives. Pharmaceuticals, 15 (4). p. 441. ISSN 1424-8247

Abstract

Cardiovascular diseases (CVDs) being one of the most prevailing chronic diseases in the 21st century with a high mortality rate. Factors such as dietary intake, physical activity, and oxidative stress are the accelerator of CVDs. Although the exact etiology and pathophysiology are still complex subjects and heavily relied upon conventional medicines. Discrete non-invasive and non-surgical methodologies are being developed for the diagnosis and treatment of CVDs. Although still in its initial stage, Nanomedicine is one such advancement capable of targeted therapy and has better efficacy and fewer side effects than conventional medicine. This review highlights the applications of nanomedicines in CVDs along with ongoing clinical research. Nanomedicine acts as a bridge towards CVDs amelioration and its management.

Item Type:	Article
Keywords:	Atherosclerosis, cardiovascular disease, clinical trials, pharmaceutical nanomedicine, targeted delivery
Date Deposited:	11 Jun 2022 00:45
Last Modified:	11 Jun 2022 00:45
URI:	https://oak.novartis.com/id/eprint/42979